The summit launched the "Connect Globally: Shanghai–London Life Sciences Innovation Partnership," fostering cooperation between institutions like Imperial College London, Oxford University Innovation, and key Shanghai development groups. This initiative seeks to integrate research and industry platforms across China and the UK. Simultaneously, the "Empower the Future" partnership united major financial players, including Jefferies Financial Group, HongShan, and CBC Group, to create a funding ecosystem capable of supporting biopharmaceutical companies throughout their entire life cycle.

Running through September 20, the event utilizes a "1+5+1+1" framework, focusing on innovation integration, clinical translation, and capital empowerment. Through closed-door discussions, project roadshows, and site tours, the summit addresses practical challenges in research commercialization. By aligning these efforts with the established Zhangjiang Pharma Valley brand, organizers aim to accelerate the commercial success of Chinese breakthroughs while strengthening the city’s status as a premier global destination for medical device and drug innovation.